Department of Medicine 5 – Haematology and Oncology

Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome (2021) Willner A, Fechner K, Agaimy A, Haller F, Eckstein M, Ott O, Putz F, et al. Journal article More on CD19-CAR T Cells in Systemic Lupus Erythematosus (2021) Mougiakakos D, Krönke G, Schett G Journal article, Letter BNT211: A PHASE I/II TRIAL TO EVALUATE SAFETY AND EFFICACY OF CLDN6 CAR-T CELLS AND VACCINE-MEDIATED IN VIVO EXPANSION IN PATIENTS WITH CLDN6-POSITIVE ADVANCED SOLID TUMORS (2021) Mackensen A, Koenecke C, Haanen J, Alsdorf W, Desuki A, Wagner-Drouet E, Heudobler D, et al. Conference contribution Variable expression of the disialoganglioside gd2 in breast cancer molecular subtypes (2021) Erber R, Kailayangiri S, Hübner H, Rübner M, Hartmann A, Häberle L, Meyer J, et al. Journal article T-Cell Metabolism in Graft Versus Host Disease (2021) Karl F, Hudecek M, Berberich-Siebelt F, Mackensen A, Mougiakakos D Journal article, Review article Head and neck melanoma: outcome and predictors in a population-based cohort study (2021) Spoerl S, Spanier G, Reiter E, Gerken M, Haferkamp S, Grosse J, Drexler K, et al. Journal article Knowledge transfer to enhance the performance of deep learning models for automated classification of B cell neoplasms (2021) Mallesh N, Zhao M, Meintker L, Hoellein A, Elsner F, Lueling H, Haferlach T, et al. Journal article Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia (2021) Rautenberg C, Stoelzel F, Roellig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, et al. Journal article RESULTS OF THE IELSG32 TRIAL AT A MEDIAN FOLLOW-UP OF 88 MONTHS DEMONSTRATE THAT MATRIX FOLLOWED BY AUTOLOGOUS TRANSPLANT IS ASSOCIATED WITH EXCELLENT SURVIVAL AND NEUROTOLERABILITY IN PATIENTS WITH PRIMARY CNS LYMPHOMA (2021) Calimeri T, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Steffanoni S, Foppoli M, et al. Conference contribution IMMUNOMONITORING OF CD19. CAR T-CELLS IN LARGE B-CELL LYMPHOMA- A TWO-CENTER EXPERIENCE (2021) Blumenberg V, Völkl S, Busch G, Baumann S, Winkelmann M, Tast B, Nixdorf D, et al. Conference contribution